Introduction
Brown adipose tissue (BAT) serves as the primary site for non-shivering thermogenesis in mammals, playing a vital role in energy expenditure and metabolic homeostasis. Unlike white adipose tissue (WAT), which stores energy as lipids, BAT dissipates energy as heat. Understanding the molecular mechanisms that govern BAT development is essential for developing therapeutic strategies against obesity and metabolic disorders. While transcription factors like PRDM16 and PPARγ are known regulators of brown adipocyte identity, the involvement of the Hippo-YAP signaling pathway—a central controller of organ size and tissue growth—has remained largely unexplored in this context.
This study identifies Vestigial like 4 (VGLL4) as a key transcriptional regulator of classical BAT development. VGLL4 is known to modulate the Hippo-YAP pathway by competing with the transcriptional co-activator YAP for binding to TEAD proteins. By investigating the role of VGLL4 in vivo, researchers have uncovered its essential function in orchestrating the adipogenic program of brown fat.
Results and Discussion
VGLL4 is Essential for BAT Formation and Perinatal Survival
To investigate the physiological role of VGLL4, the researchers generated a conventional Vgll4 mutant mouse line (referred to as $Vko$) in which the two Tondu (TDU) domains—critical for protein-protein interactions—were disrupted. The loss of functional VGLL4 resulted in perinatal lethality, with mutant pups exhibiting a striking absence of visible interscapular BAT.
Advanced imaging techniques, including Magnetic Resonance Imaging (MRI) and microCT, confirmed a significant reduction in BAT volume and lipid accumulation in the $Vko$ mutants. Histological analysis further revealed a paucity of brown adipocytes and a dramatic decrease in the expression of the thermogenic marker Uncoupling Protein 1 (UCP1). These findings establish VGLL4 as a fundamental requirement for the initial formation and maturation of classical BAT.
The Molecular Mechanism: Releasing the Adipogenic Brake
The study elucidated a novel regulatory mechanism involving a "competitive switch" between VGLL4 and TEAD1. In many tissues, VGLL4 acts as a brake on YAP-mediated growth. However, in BAT development, the researchers found that TEAD1 normally suppresses the expression of Cebpb (CEBPβ), a master regulator of adipogenesis.
VGLL4 functions as a "releaser" by binding to TEAD1 and preventing it from inhibiting the Cebpb promoter. This interaction effectively green-lights the adipogenic program. Furthermore, genomic analysis using bioChIP-seq and RNA-seq revealed that the VGLL4/TEAD1 complex directly regulates genes associated with both adipogenesis and myogenic programs. This dual regulation is consistent with the known developmental origin of classical brown fat, which shares a common progenitor with skeletal muscle.
Therapeutic Potential: Enhancing Thermogenic Capacity
To explore the potential for metabolic intervention, the authors utilized an Adeno-associated virus (AAV9) vector to overexpress VGLL4 specifically in the BAT of adult mice. This was achieved using a brown adipocyte-specific promoter (BCE) derived from the Ucp1 gene.
The results were significant: brown-adipocyte-specific overexpression of VGLL4 led to a ~21% increase in BAT volume (102.2 $mm^3$ compared to 84.16 $mm^3$ in controls). More importantly, this increase in tissue volume translated to improved physiological function. During an acute cold stress challenge (4°C for 24 hours), male mice overexpressing VGLL4 maintained a significantly higher core body temperature (~37.8°C) compared to control mice (~35.3°C), demonstrating enhanced thermogenic resilience.
Genomic Targets and the UCP1 Paradox
The study identified Casq1 (Calsequestrin 1) as a direct target of the VGLL4/TEAD1/CEBPβ complex. Casq1 is involved in calcium handling, suggesting that VGLL4 might regulate thermogenesis through mechanisms beyond the classical UCP1-mediated pathway. This is supported by the observation that while VGLL4 increased BAT volume and cold tolerance, it did not significantly increase (and in some cases slightly decreased) UCP1 mRNA levels in certain contexts. This "UCP1 paradox" suggests that VGLL4 may promote UCP1-independent thermogenic pathways, such as calcium cycling.
Conclusion and Future Directions
VGLL4 is a previously unrecognized factor essential for the development and functional capacity of classical brown adipose tissue. By modulating the Hippo-TEAD axis, VGLL4 ensures the proper execution of the adipogenic program.
Several questions remain for future investigation. The thermogenic protection observed in this study was specific to male mice, indicating a potential sexual dimorphism in VGLL4 function that requires further study. Additionally, because the whole-body knockout is perinatally lethal, the use of conditional (Cre-lox) models will be necessary to determine if VGLL4 is required for the maintenance of BAT in adult animals. Understanding these nuances could pave the way for targeting the VGLL4 pathway to treat metabolic diseases.
Summary updated